RYBELSUS

Drug Novo Nordisk Inc
Total Payments
$30.3M
Transactions
145,859
Doctors
42,831
Companies
2

Payment Trends by Year

Year Amount Transactions Doctors
2021 $20.2M 119,934 41,366
2020 $10.1M 25,815 4,331
2019 $57,093 110 0

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $14.1M 37,677 46.5%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $12.2M 6,777 40.2%
Food and Beverage $2.8M 97,753 9.3%
Travel and Lodging $727,959 3,006 2.4%
Consulting Fee $482,965 505 1.6%
Space rental or facility fees (teaching hospital only) $1,000 1 0.0%
Education $612.12 140 0.0%

Payments by Type

General
$16.2M
108,182 transactions
Research
$14.1M
37,677 transactions

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
EX9924-4473 Novo Nordisk AS $10.1M 32
NN9924-4635 Novo Nordisk AS $2.7M 2
NN9924-4437 Novo Nordisk AS $552,427 4
NN6535-4725 Novo Nordisk AS $347,572 3
NN9924-4669 Novo Nordisk AS $117,298 0
NN9924-4558 Novo Nordisk AS $71,953 0
EX9924-4473 Novo Nordisk Inc $64,537 6
NN9924-4257 Novo Nordisk AS $28,883 0
NN9924-4309 Novo Nordisk AS $21,150 13
NN9924-4280 Novo Nordisk AS $20,772 0
NN9924-4558 Novo Nordisk Inc $18,300 4
NN9924-4558-001 Novo Nordisk AS $15,444 0
NN9931-4296 Novo Nordisk AS $14,220 0
NN9931-4492 Novo Nordisk AS $13,650 0
NN9924-4338 Novo Nordisk AS $10,625 16
NN9924-4473 Novo Nordisk AS $2,778 1
EX9536-4388 Novo Nordisk AS $1,275 2
NN9924-4473 Novo Nordisk Inc $800.00 1
NN9924-4221 Novo Nordisk AS $600.00 0
NN9536-4374 Novo Nordisk AS $375.00 1

Top Doctors Receiving Payments for RYBELSUS — Page 5

Doctor Specialty Location Total Records
, MD, MS Interventional Cardiology Reno, NV $43,644 17
, MD Endocrinology, Diabetes & Metabolism Edgewater, FL $43,106 34
, MD Endocrinology, Diabetes & Metabolism Charlotte, NC $42,767 52
, MD Internal Medicine New York, NY $42,763 42
, MD Internal Medicine Scarborough, ME $42,677 41
, M.D Cardiovascular Disease Torrance, CA $42,155 20
, M.D Endocrinology, Diabetes & Metabolism Atlanta, GA $42,047 42
, M.D Internal Medicine Jefferson City, MO $41,804 41
, MD Endocrinology, Diabetes & Metabolism Raleigh, NC $41,240 57
, M.D Internal Medicine San Antonio, TX $41,121 43
, MD Endocrinology, Diabetes & Metabolism Raleigh, NC $41,029 45
, MD Endocrinology, Diabetes & Metabolism Jackson, MS $40,843 38
, MD Endocrinology, Diabetes & Metabolism Springfield, MO $40,440 42
, M.D Endocrinology, Diabetes & Metabolism Lewisburg, PA $40,178 41
, M.D Endocrinology, Diabetes & Metabolism Memphis, TN $39,936 29
, M.D Endocrinology, Diabetes & Metabolism Tarzana, CA $39,764 34
, MD Endocrinology, Diabetes & Metabolism Burlington, NC $38,960 34
, M.D Endocrinology, Diabetes & Metabolism Greensburg, PA $38,609 57
, M.D Endocrinology, Diabetes & Metabolism Macon, GA $38,549 39
, MD Interventional Cardiology Chapel Hill, NC $38,336 15
, MD Family Medicine Elk City, OK $38,178 37
, MD Internal Medicine Mobile, AL $38,116 44
, MD Internal Medicine Cleveland, OH $37,611 45
, D.O Obesity Medicine Sisters, OR $37,451 51
, MD Endocrinology, Diabetes & Metabolism Branford, CT $37,268 49
«1…34567…1714»

Manufacturing Companies

Product Information

  • Type Drug
  • Total Payments $30.3M
  • Total Doctors 42,831
  • Transactions 145,859

About RYBELSUS

RYBELSUS is a drug associated with $30.3M in payments to 42,831 healthcare providers, recorded across 145,859 transactions in the CMS Open Payments database. The primary manufacturer is Novo Nordisk Inc.

Payment data is available from 2019 to 2021. In 2021, $20.2M was paid across 119,934 transactions to 41,366 doctors.

The most common payment nature for RYBELSUS is "Unspecified" ($14.1M, 46.5% of total).

RYBELSUS is associated with 20 research studies, including "EX9924-4473" ($10.1M).